TP53 and osteosarcoma: Studies demonstrated that SKP2 deletion results in a proliferation of macrophages, correlating with a favorable prognosis in osteosarcoma patients, indicating a suppressive effect on tumor development and dissemination in the Rb1/p53-deficient mouse osteosarcoma model (Ferrena et al., 2023).